Association of tobacco and marijuana use with symptoms of depression and anxiety among adolescents and young adults in Texas.
Association of tobacco and marijuana use with symptoms of depression and anxiety among adolescents and young adults in Texas.
复制标题
DOI：
10.18332/tpc/144500
复制
发表时间：
2022
影响因子：
1.8
通讯作者：
Harrell MB
中科院分区：
文献类型：
--
作者：
Sumbe A;Wilkinson AV;Clendennen SL;Bataineh BS;Sterling KL;Chen B;Harrell MB
患有抑郁症和/或焦虑症的年轻人可以用烟草或烟草加大麻进行自我治疗，以减轻症状。本研究试图区分烟草制品的预期使用和烟草制品的改造以适应大麻的使用，并探索它们与青少年和年轻人的抑郁和焦虑症状的关系。该研究是对来自德克萨斯州青少年烟草和营销监测（TATAMS） （n=2439, n= 274030）的第9波（2019年春季）数据的二次分析。分别用GAD-7和PHQ-9测量焦虑和重度抑郁症状。报告当前使用不含大麻的电子烟的几率（调整后的患病率优势比，APOR=2.34; 95% CI: 1.30-4.21, p=0.005）和当前使用不含大麻的可燃烟草的几率（APOR=2.99; 95% CI: 1.26-7.09, p=0.014）在报告有抑郁/焦虑共病的人群中显著高于无重度抑郁症状（MDS）、焦虑或共病的人群。与无MDS症状、焦虑或合并症的患者相比，仅报告MDS的患者报告曾经同时使用电子烟和大麻的几率（APOR=3.68; 95% CI: 1.69 - 8.00, p=0.001）、目前同时使用电子烟和大麻的几率（APOR=2.76; 95% CI: 1.28-5.97, p=0.01）和曾经同时使用可燃烟草和大麻的几率（APOR=3.99; 95% CI: 1.66-9.58, p=0.002）显著更高。研究结果可以对干预计划产生影响，因为干预需要解决烟草产品中大麻和尼古丁的使用问题，并解决焦虑和抑郁问题。
Young people with depression and/or anxiety may self-medicate with tobacco or tobacco with marijuana to reduce their symptoms. This study sought to differentiate between the use of tobacco products as intended and tobacco products modified to accommodate marijuana, and to explore their relationships with symptoms of depression and anxiety among youth and young adults. The study is a secondary analysis of Wave 9 (Spring 2019) data from the Texas Adolescent Tobacco and Marketing Surveillance (TATAMS) (n=2439, N=274030). Anxiety and major depressive symptoms were measured by GAD-7 and PHQ-9, respectively. The odds of reporting current use of e-cigarettes without marijuana (adjusted prevalence odds ratio, APOR=2.34; 95% CI: 1.30–4.21, p=0.005) and current use of combustible tobacco without marijuana (APOR=2.99; 95% CI: 1.26–7.09, p=0.014) were significantly higher among those who reported depression/anxiety comorbidity compared to those who reported no symptoms of major depressive symptoms (MDS), anxiety or comorbidity. The odds of reporting ever use of e-cigarettes with marijuana (APOR=3.68; 95% CI: 1.69– 8.00, p=0.001), current use of e-cigarettes with marijuana (APOR=2.76; 95% CI: 1.28–5.97, p=0.01) and ever use of combustible tobacco with marijuana (APOR=3.99; 95% CI: 1.66–9.58, p=0.002) were significantly higher among those reporting only MDS compared to those who reported no symptoms of MDS, anxiety or comorbidity. The study findings can have implications for intervention planning, as interventions need to address marijuana and nicotine use in tobacco products and address anxiety and depression.
登录
查看更多内容
影响因子：
2
作者：
Berg CJ;Payne J;Henriksen L;Cavazos-Rehg P;Getachew B;Schauer GL;Haardörfer R
通讯作者：
Haardörfer R
影响因子：
4.7
作者：
Bandiera, Frank C.;Loukas, Alexandra;Perry, Cheryl L.
通讯作者：
Perry, Cheryl L.
影响因子：
4.4
作者：
Seaman, Elizabeth L.;Stanton, Cassandra A.;Halenar, Michael J.
通讯作者：
Halenar, Michael J.
影响因子：
0.5
作者：
Kroenke, K;Spitzer, RL
通讯作者：
Spitzer, RL
影响因子：
3.4
作者：
Johnson, Kirsten A.;Bonn-Miller, Marcel O.;Zvolensky, Michael J.
通讯作者：
Zvolensky, Michael J.